The challenges and demands of pharmacovigilance in today’s climate has shifted significantly. How do we determine what should and can be sourced differently compared to our traditional models? Offshore-outsourced blended models are becoming increasingly popular. Join this webinar for a discussion of the challenges and benefits of the different sourcing models to manage pharmacovigilance in a compliant and efficient manner.
Humaira Qureshi, SVP of Pharmacovigilance, Bioclinica
Humaira Qureshi is SVP of Pharmacovigilance at Bioclinica and has spent her career in pharmacovigilance where she implemented pharmacovigilance operational solutions for several of the top 10 Global Pharmaceutical companies. She is an expert lecturer on numerous pharmacovigilance topics to both industry and academic audiences such as the Drug Safety Research Unit (DRSU), and the University of Hertfordshire.
Prior to Bioclinica, Humaira was with Kinapse, headquartered in the UK, where she spent over seven years leading both the operational and strategic initiatives within thepharmacovigilance business. While at Kinapse she established and lead the pharmacovigilance service line from scratch and created year-on-year growth from financial, resource and client pool aspects. Before Kinapse, she held several management positions with Norgine and Ipsen, also in the UK. Humaira holds a Bachelor of Science in Medicinal Biochemistry from the University of London.Message Presenter
Who Should Attend?
This webinar will benefit senior-level drug development professionals, with relevant job titles including:
- (Drug) Safety/Safety Operations or Pharmacovigilance
- Medical Director of Pharmacovigilance and Patient Safety
- Drug Safety Operations and Risk Management
- Patient Safety
- Aggregate Reporting
- QPPV (Qualified Person for Pharmacovigilance)
- Clinical Development and Product Safety
- Global Direct Safety
- Benefit & Risk
- Safety Leader
- Medical Writing
- Medical Scientific Liaison
- Strategic Planning
- Signal Detection
- Head of Therapeutic Areas
What You Will Learn
Join this webinar for a discussion of:
- The challenges and benefits of different sourcing models to manage pharmacovigilance
- How to determine what should and can be sourced differently compared to traditional models
- Why offshore-outsourced blended models are becoming increasingly popular
Bioclinica is a global life sciences solution provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company’s cloud-based offerings include medical imaging; cardiac safety; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site payments and forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers an integrated App xChange partner ecosystem, a global network of research sites, patient recruitment services, and post-approval research expertise to provide committed, detail-focused service through all stages of drug development. The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.